Rankings
▼
Calendar
▼
CYCN FY 2016 Earnings Report — Cyclerion Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena
Cyclerion Therapeutics, Inc.
CYCN
FY 2016 Earnings
Reported December 29, 2016
Quarter Comparison
Revenue
Operating Income
EPS (Diluted)
Free Cash Flow
Metric
FY 2016
Prior Q
FY 2015
QoQ Change
YoY Change
Revenue
$0
—
—
—
—
Op. Income
-$64M
—
—
—
—
EPS (Diluted)
$-46.39
—
—
—
—
Free Cash Flow
-$51M
—
—
—
—
marketcaparena.com
Income Statement
Item
Amount
REVENUE
$0
Cost of Revenue
$2M
GROSS PROFIT
-$2M
R&D Expenses
$51M
Selling & Marketing
$0
General & Administrative
$0
SG&A Expenses
$10M
Other Expenses
$0
Operating Expenses
$61M
Cost & Expenses
$64M
OPERATING INCOME
-$64M
Interest Income
$0
Interest Expense
$0
Other Income/Expenses
$0
INCOME BEFORE TAX
-$64M
Income Tax Expense
$0
Net Income from Continuing Ops
-$64M
Net Income from Discontinued Ops
$0
Other Adjustments
$0
NET INCOME
-$64M
Net Income Deductions
$0
BOTTOM LINE NET INCOME
-$64M
D&A
$2M
EBIT
-$64M
EBITDA
-$61M
EPS
-$46
EPS Diluted
-$46
marketcaparena.com
Cash Flow Statement
Item
Amount
Net Income
-$64M
Depreciation & Amortization
$2M
Stock-Based Compensation
$0
Deferred Income Tax
$0
Other Non-Cash Items
$11M
Change in Working Capital
$4M
OPERATING CASH FLOW
-$50M
Capital Expenditure
-$1M
Acquisitions (Net)
$0
Purchases of Investments
$0
Sales/Maturities of Investments
$0
Other Investing Activities
$0
NET CASH FROM INVESTING
-$1M
Net Debt Issuance
$0
Common Stock Repurchased
$0
Common Dividends Paid
$0
Other Financing Activities
$51M
NET CASH FROM FINANCING
$51M
FREE CASH FLOW
-$51M
Net Change in Cash
$0
marketcaparena.com
← Q3 2017
CYCN Overview